Archives

by in
Entry Author Date Location
Houston Cancer Diagnostics Firm Castle Biosciences Raises $11.8M 08/13/14 Texas
West Coast Biotech Roundup: MappBio, Juno, Zosano, and More 08/07/14 San Diego
Military Strategies Being Used in the War on Cancer 08/04/14 Seattle
DiBS’s BioWheel Aims to Paint a Dynamic Picture of Life Sciences Data 08/01/14 Texas
Epic Sciences Raises $30M to Advance Cancer Diagnostics 07/30/14 San Diego
West Coast Biotech Roundup: IPOs, Gilead, Sofinnova, & Denouements 07/25/14 San Diego
Cypher Genomics’ Analytics Tech Gains Some Cred in Illumina Deal 07/24/14 San Diego
Gilead Edges Into Cancer Field With FDA OK of Calistoga Drug 07/23/14 San Francisco
Cellectar, an OTC Stock, Eyes Nasdaq Jump to Boost Profile, Prospects 07/22/14 Wisconsin
How Seragon CEO Rich Heyman Made Lightning Strike Twice 07/16/14 San Diego
CPRIT Executives Outline Cancer-Fighting Priorities in Houston Visit 07/14/14 Texas
New Jounce CEO Aims to Place the Right Immuno-Oncology Bets 07/11/14 Boston
Jounce Taps Merck Vet to Lead Cancer Drug Push 07/10/14 Boston
West Coast Biotech Roundup: Seragon, Ambrx, Pregenen, and More 07/03/14 San Diego
VenBio Scores Again as Genentech Pays $1.7B+ for Seragon Pharma 07/02/14 San Diego
BIO 2014: Innovations in 3-D Tissue for Disease and Drug Discovery 06/26/14 San Diego
BIO 2014: Antisense and Disruptive Technologies for Drug Discovery 06/23/14 San Diego
Sanofi Punts Cancer Drug Back to Merrimack 06/19/14 Boston
BIO 2014: An Industry Surrounded by Insurmountable Opportunity 06/19/14 San Diego
With J&J Deals, Aduro’s Cancer Vaccines Have New Chance To Prove Worth 06/18/14 San Francisco
East Coast Biotech Roundup: Accelerate LI, ASCO, Akebia, & More 06/09/14 Boston
Clovis Shares Tumble as Analysts Give Edge to Lung-Cancer Rival 06/04/14 Boulder/Denver
Promedior Sees Hope in Small Myelofibrosis Study 05/30/14 Boston
Prostate Cancer Screening: Seduction Of The Innocent 05/28/14 Seattle
New Funding, Commercialization Officer at Texas Cancer Agency 05/22/14 Texas
OncoGenex Retrenches, and Searches for Answers, After Failed Trial 05/22/14 Seattle
As Expected, Nurix Taps Into $25M for New Drug Discovery 05/22/14 San Francisco
ZS Pharma Ends Texas Biotech IPO Dry Spell With $86M Pitch 05/20/14 Texas
Tesaro Climbs on Phase 3 Data for Nausea Drug 05/12/14 Boston
West Coast Biotech Roundup: Alder IPO, Exelixis, Corcept, and More 05/09/14 San Diego
Page 2 of 57 « previous page · next page »